JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TCP
801
DELISTED
TC Pipelines LP
TCP
| $62.7M | 0.01% |
2,017,544
+100,201
| +5% | +$3.3M |
2013 Q2
28 quarters
|
|
802
Evergy
EVRG
$18.3B
| $62.6M | 0.01% |
1,055,132
+322,982
| +44% | +$19.1M |
2018 Q2
8 quarters
|
|
803
National Health Investors
NHI
$3.23B
| $62.5M | 0.01% |
1,028,883
-20,788
| -2% | -$1.14M |
2014 Q4
22 quarters
|
|
804
iShares Russell 2000 Growth ETF
IWO
$14.1B
| $62.3M | 0.01% |
301,268
+51,538
| +21% | +$9.64M |
2013 Q2
28 quarters
|
|
805
TTM Technologies
TTMI
$13.9B
| $61.9M | 0.01% |
5,219,219
+1,859,805
| +55% | +$20.7M |
2013 Q2
28 quarters
|
|
806
DaVita
DVA
$11.4B
| $61.8M | 0.01% |
781,088
-120,048
| -13% | -$9.37M |
2013 Q2
28 quarters
|
|
807
Grocery Outlet
GO
$1.15B
| $61.7M | 0.01% |
1,511,250
+191,264
| +14% | +$6.85M |
2019 Q2
4 quarters
|
|
808
Genesis Energy
GEL
$1.72B
| $61.5M | 0.01% |
8,520,968
+3,880,440
| +84% | +$26.3M |
2013 Q2
28 quarters
|
|
809
PUT
Deutsche Bank
DB
$65.7B
| $61.4M | 0.01% |
6,454,700
+1,409,000
| +28% | +$10.9M |
2013 Q2
28 quarters
|
|
810
iShares Russell 1000 ETF
IWB
$49.1B
| $61.3M | 0.01% |
357,084
-156,896
| -31% | -$25.4M |
2013 Q2
28 quarters
|
|
|
811
Deutsche Bank
DB
$65.7B
| $61M | 0.01% |
6,408,990
+3,228,459
| +102% | +$25M |
2013 Q2
28 quarters
|
|
812
First Financial Bancorp
FFBC
$3.35B
| $60.7M | 0.01% |
4,369,719
+310,470
| +8% | +$4.28M |
2013 Q2
28 quarters
|
|
|
AZEK
813
DELISTED
The AZEK Co
AZEK
| $60.6M | 0.01% |
+1,902,638
| New | +$57.8M |
2020 Q2
0 quarters
|
|
814
Atara Biotherapeutics
ATRA
$95.2M
| $60.5M | 0.01% |
166,201
+51,391
| +45% | +$13M |
2017 Q4
10 quarters
|
|
815
Allogene Therapeutics
ALLO
$518M
| $60.4M | 0.01% |
1,410,446
+1,022,462
| +264% | +$37M |
2018 Q4
6 quarters
|
|
816
iShares Core S&P Small-Cap ETF
IJR
$105B
| $60.4M | 0.01% |
883,774
-171,426
| -16% | -$10.8M |
2013 Q2
28 quarters
|
|
|
COR
817
DELISTED
Coresite Realty Corporation
COR
| $60M | 0.01% |
496,008
-5,389
| -1% | -$648K |
2013 Q2
28 quarters
|
|
818
CALL
UBS Group
UBS
$146B
| $59.9M | 0.01% |
5,192,000
-1,323,600
| -20% | -$13.6M |
2018 Q3
7 quarters
|
|
819
Vanguard Short-Term Corporate Bond ETF
VCSH
$44B
| $59.9M | 0.01% |
724,041
+294,786
| +69% | +$24M |
2013 Q2
28 quarters
|
|
820
Conagra Brands
CAG
$6.38B
| $59.8M | 0.01% |
1,701,376
-122,496
| -7% | -$4.08M |
2013 Q2
28 quarters
|
|
821
Boyd Gaming
BYD
$4.89B
| $58.7M | 0.01% |
2,806,499
+27,347
| +1% | +$499K |
2013 Q2
28 quarters
|
|
822
Wheaton Precious Metals
WPM
$61.9B
| $58.7M | 0.01% |
1,331,572
+22,742
| +2% | +$895K |
2013 Q2
28 quarters
|
|
823
Bilibili
BILI
$5.95B
| $58.6M | 0.01% |
1,265,268
+486,165
| +62% | +$15.8M |
2018 Q1
9 quarters
|
|
824
Stryker
SYK
$106B
| $58.5M | 0.01% |
324,760
+76,975
| +31% | +$14.2M |
2013 Q2
28 quarters
|
|
825
BCE
BCE
$18.4B
| $58.2M | 0.01% |
1,393,611
-529,559
| -28% | -$21.8M |
2013 Q2
28 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.